Spectral AI, Inc. (ticker: MDAI) is an NASDAQ-listed clinical biotech company. DredgeCap's structured extraction of MDAI's SEC filings surfaces 5 active risk signals, including 2 auditor-change signals, 2 late-filing signals, and 1 delisting/deregistration signal. MDAI reported $3.99M in revenue and -$3.41M for the period ending 2026-03-31, with operating cash flow of -$3.73M. Cash and equivalents stood at $11.70M (down 17% year-over-year). Total assets of $17.73M are exceeded by total liabilities of $26.54M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
MDAI Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Spectral AI, Inc. (MDAI) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.